Share Price and Basic Stock Data
Last Updated: January 14, 2026, 3:44 pm
| PEG Ratio | -3.18 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Morganite Crucible (India) Ltd operates in the refractories industry, focusing on high-performance materials essential for various industrial applications. The company’s market capitalization stood at ₹865 Cr, with its share price at ₹1,545. Over the past fiscal years, Morganite has demonstrated a consistent revenue growth trajectory, with sales rising from ₹152 Cr in FY 2022 to ₹155 Cr in FY 2023, and further projected to increase to ₹168 Cr in FY 2024 and ₹174 Cr in FY 2025. Quarterly sales figures also reflect positive momentum, with revenues recorded at ₹45.35 Cr in September 2023, up from ₹42.69 Cr in June 2023. This upward trend showcases the company’s ability to adapt to market demands while maintaining a steady growth rate, as evidenced by a 6% year-over-year increase in sales from FY 2023 to FY 2024.
Profitability and Efficiency Metrics
Morganite Crucible has reported impressive profitability metrics, highlighted by a return on equity (ROE) of 21.4% and a return on capital employed (ROCE) of 30.4%. The operating profit margin (OPM) stood at 27.80%, indicating robust operational efficiency compared to typical industry averages. The company achieved an operating profit of ₹41 Cr for FY 2025, up from ₹39 Cr in FY 2024, showcasing effective cost management despite rising expenses, which increased from ₹129 Cr in FY 2023 to ₹133 Cr in FY 2025. Moreover, the net profit for FY 2025 was recorded at ₹28 Cr, demonstrating a significant recovery from the previous year’s net profit of ₹16 Cr. The cash conversion cycle (CCC) is notably efficient at just 2 days, reflecting the company’s ability to quickly convert its investments in inventory and accounts receivable into cash.
Balance Sheet Strength and Financial Ratios
The balance sheet of Morganite Crucible exhibits a strong financial position, with total borrowings limited to ₹2 Cr, indicating minimal leverage and a conservative approach to debt management. The reserves have grown steadily, reaching ₹133 Cr by FY 2025, up from ₹124 Cr in FY 2023. The company’s price-to-book value (P/BV) ratio stands at 2.83x, suggesting a premium valuation compared to its book value. Additionally, the interest coverage ratio is reported at 0.00x, reflecting zero interest expenses, which underscores the absence of debt-related financial strain. The company’s current ratio is robust at 4.01, indicating solid liquidity and the ability to cover short-term obligations. This financial stability positions Morganite Crucible favorably against its peers, enhancing its attractiveness to investors.
Shareholding Pattern and Investor Confidence
The shareholding structure of Morganite Crucible reveals a strong promoter backing, with promoters holding 75% of the equity. This significant ownership provides stability and aligns the interests of management with those of shareholders. Foreign institutional investors (FIIs) and domestic institutional investors (DIIs) have minimal stakes, at 0.18% and 1.13% respectively, indicating limited external institutional interest. The public holds 23.70% of the shares, reflecting a moderate level of retail investor participation. The total number of shareholders has increased to 7,455 as of September 2025, suggesting growing interest among retail investors. However, the low FII and DII participation could also be viewed as a potential risk factor, as increased institutional investment typically reflects broader market confidence in a company’s prospects.
Outlook, Risks, and Final Insight
Looking ahead, Morganite Crucible appears well-positioned for continued growth, bolstered by its strong financial metrics and efficient operations. However, the company faces risks including potential volatility in raw material costs and changes in demand from key industrial sectors. Additionally, the relatively low institutional ownership may hinder its stock performance during periods of market uncertainty. Should the company maintain its operational efficiency and navigate these risks effectively, it could capitalize on opportunities for expansion and increased market share. Conversely, failure to manage cost pressures or a downturn in demand could adversely affect profitability. Overall, Morganite Crucible’s solid fundamentals suggest a positive long-term outlook, contingent upon its ability to adapt to market dynamics and maintain shareholder confidence.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Morganite Crucible (India) Ltd | 823 Cr. | 1,470 | 1,964/1,170 | 32.6 | 242 | 3.33 % | 30.4 % | 21.4 % | 5.00 |
| Associated Ceramics Ltd | 65.3 Cr. | 217 | 264/177 | 20.3 | 86.2 | 0.00 % | 10.8 % | 9.55 % | 10.0 |
| Vesuvius India Ltd | 9,344 Cr. | 460 | 647/356 | 38.3 | 75.0 | 0.31 % | 25.5 % | 19.3 % | 1.00 |
| IFGL Refractories Ltd | 1,398 Cr. | 194 | 340/163 | 47.0 | 158 | 1.80 % | 5.71 % | 3.94 % | 10.0 |
| Industry Average | 3,855.00 Cr | 585.25 | 34.55 | 140.30 | 1.36% | 18.10% | 13.55% | 6.50 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 38.85 | 41.49 | 33.98 | 42.69 | 45.35 | 40.00 | 39.90 | 42.90 | 44.31 | 44.66 | 42.32 | 42.54 | 45.93 |
| Expenses | 31.94 | 33.43 | 30.23 | 31.19 | 32.51 | 31.50 | 34.28 | 32.12 | 31.48 | 34.18 | 35.77 | 33.41 | 33.16 |
| Operating Profit | 6.91 | 8.06 | 3.75 | 11.50 | 12.84 | 8.50 | 5.62 | 10.78 | 12.83 | 10.48 | 6.55 | 9.13 | 12.77 |
| OPM % | 17.79% | 19.43% | 11.04% | 26.94% | 28.31% | 21.25% | 14.09% | 25.13% | 28.96% | 23.47% | 15.48% | 21.46% | 27.80% |
| Other Income | 0.23 | 1.82 | 1.64 | 1.15 | 1.12 | 2.83 | -2.20 | 1.96 | 1.75 | 2.75 | 1.52 | 2.11 | 2.51 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.06 | 0.03 | 0.08 | 0.08 | 0.05 | 0.03 | 0.04 | 0.04 |
| Depreciation | 1.94 | 2.02 | 2.03 | 2.04 | 2.21 | 2.11 | 2.09 | 1.95 | 2.17 | 2.31 | 2.62 | 2.77 | 2.82 |
| Profit before tax | 5.20 | 7.86 | 3.36 | 10.61 | 11.71 | 9.16 | 1.30 | 10.71 | 12.33 | 10.87 | 5.42 | 8.43 | 12.42 |
| Tax % | 25.00% | 24.94% | 40.77% | 26.48% | 29.04% | 27.07% | 46.92% | 26.33% | 27.74% | 27.78% | 46.86% | 31.55% | 29.39% |
| Net Profit | 3.91 | 5.90 | 1.99 | 7.80 | 8.31 | 6.67 | 0.70 | 7.90 | 8.92 | 7.85 | 2.88 | 5.77 | 8.78 |
| EPS in Rs | 6.98 | 10.54 | 3.55 | 13.93 | 14.84 | 11.91 | 1.25 | 14.11 | 15.93 | 14.02 | 5.14 | 10.30 | 15.68 |
Last Updated: January 6, 2026, 8:06 pm
Below is a detailed analysis of the quarterly data for Morganite Crucible (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 45.93 Cr.. The value appears strong and on an upward trend. It has increased from 42.54 Cr. (Jun 2025) to 45.93 Cr., marking an increase of 3.39 Cr..
- For Expenses, as of Sep 2025, the value is 33.16 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 33.41 Cr. (Jun 2025) to 33.16 Cr., marking a decrease of 0.25 Cr..
- For Operating Profit, as of Sep 2025, the value is 12.77 Cr.. The value appears strong and on an upward trend. It has increased from 9.13 Cr. (Jun 2025) to 12.77 Cr., marking an increase of 3.64 Cr..
- For OPM %, as of Sep 2025, the value is 27.80%. The value appears strong and on an upward trend. It has increased from 21.46% (Jun 2025) to 27.80%, marking an increase of 6.34%.
- For Other Income, as of Sep 2025, the value is 2.51 Cr.. The value appears strong and on an upward trend. It has increased from 2.11 Cr. (Jun 2025) to 2.51 Cr., marking an increase of 0.40 Cr..
- For Interest, as of Sep 2025, the value is 0.04 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.04 Cr..
- For Depreciation, as of Sep 2025, the value is 2.82 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.77 Cr. (Jun 2025) to 2.82 Cr., marking an increase of 0.05 Cr..
- For Profit before tax, as of Sep 2025, the value is 12.42 Cr.. The value appears strong and on an upward trend. It has increased from 8.43 Cr. (Jun 2025) to 12.42 Cr., marking an increase of 3.99 Cr..
- For Tax %, as of Sep 2025, the value is 29.39%. The value appears to be improving (decreasing) as expected. It has decreased from 31.55% (Jun 2025) to 29.39%, marking a decrease of 2.16%.
- For Net Profit, as of Sep 2025, the value is 8.78 Cr.. The value appears strong and on an upward trend. It has increased from 5.77 Cr. (Jun 2025) to 8.78 Cr., marking an increase of 3.01 Cr..
- For EPS in Rs, as of Sep 2025, the value is 15.68. The value appears strong and on an upward trend. It has increased from 10.30 (Jun 2025) to 15.68, marking an increase of 5.38.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:29 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 81 | 89 | 89 | 111 | 109 | 120 | 129 | 107 | 152 | 155 | 168 | 174 | 175 |
| Expenses | 64 | 70 | 68 | 83 | 86 | 100 | 111 | 96 | 122 | 129 | 129 | 133 | 137 |
| Operating Profit | 17 | 18 | 20 | 29 | 23 | 20 | 17 | 10 | 30 | 25 | 39 | 41 | 39 |
| OPM % | 21% | 21% | 23% | 26% | 21% | 17% | 13% | 10% | 20% | 16% | 23% | 24% | 22% |
| Other Income | 2 | 0 | 2 | 2 | 3 | 6 | 7 | 1 | 32 | 5 | 3 | 8 | 9 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 5 | 8 | 7 | 5 | 4 | 4 | 5 | 6 | 7 | 8 | 8 | 9 | 11 |
| Profit before tax | 13 | 11 | 16 | 26 | 21 | 22 | 18 | 6 | 54 | 22 | 33 | 39 | 37 |
| Tax % | 37% | 44% | 36% | 37% | 35% | 30% | 29% | 116% | 20% | 28% | 28% | 30% | |
| Net Profit | 8 | 6 | 10 | 17 | 14 | 15 | 13 | -1 | 43 | 16 | 23 | 28 | 25 |
| EPS in Rs | 15.04 | 10.75 | 17.64 | 29.64 | 24.79 | 27.45 | 23.43 | -1.66 | 77.48 | 28.79 | 41.95 | 49.18 | 45.14 |
| Dividend Payout % | 3% | 5% | 11% | 13% | 32% | 29% | 34% | 0% | 70% | 69% | 95% | 100% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -25.00% | 66.67% | 70.00% | -17.65% | 7.14% | -13.33% | -107.69% | 4400.00% | -62.79% | 43.75% | 21.74% |
| Change in YoY Net Profit Growth (%) | 0.00% | 91.67% | 3.33% | -87.65% | 24.79% | -20.48% | -94.36% | 4507.69% | -4462.79% | 106.54% | -22.01% |
Morganite Crucible (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 6% |
| 3 Years: | 5% |
| TTM: | 3% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 16% |
| 3 Years: | -7% |
| TTM: | -1% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 12% |
| 3 Years: | 20% |
| 1 Year: | -6% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 17% |
| 3 Years: | 18% |
| Last Year: | 21% |
Last Updated: September 5, 2025, 3:51 pm
Balance Sheet
Last Updated: January 7, 2026, 5:42 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Reserves | 53 | 58 | 67 | 77 | 88 | 96 | 105 | 100 | 120 | 124 | 126 | 129 | 133 |
| Borrowings | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 1 | 1 | 2 |
| Other Liabilities | 27 | 14 | 18 | 38 | 23 | 28 | 32 | 37 | 32 | 34 | 45 | 37 | 27 |
| Total Liabilities | 82 | 75 | 88 | 118 | 114 | 127 | 139 | 139 | 155 | 161 | 174 | 170 | 164 |
| Fixed Assets | 23 | 18 | 15 | 25 | 27 | 31 | 32 | 30 | 38 | 53 | 62 | 81 | 83 |
| CWIP | 0 | 1 | 3 | 2 | 0 | 4 | 19 | 22 | 15 | 1 | 0 | 4 | 2 |
| Investments | 5 | 5 | 5 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Other Assets | 54 | 51 | 65 | 91 | 87 | 93 | 88 | 87 | 102 | 106 | 112 | 86 | 80 |
| Total Assets | 82 | 75 | 88 | 118 | 114 | 127 | 139 | 139 | 155 | 161 | 174 | 170 | 164 |
Below is a detailed analysis of the balance sheet data for Morganite Crucible (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 3.00 Cr..
- For Reserves, as of Sep 2025, the value is 133.00 Cr.. The value appears strong and on an upward trend. It has increased from 129.00 Cr. (Mar 2025) to 133.00 Cr., marking an increase of 4.00 Cr..
- For Borrowings, as of Sep 2025, the value is 2.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1.00 Cr. (Mar 2025) to 2.00 Cr., marking an increase of 1.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 27.00 Cr.. The value appears to be improving (decreasing). It has decreased from 37.00 Cr. (Mar 2025) to 27.00 Cr., marking a decrease of 10.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 164.00 Cr.. The value appears to be improving (decreasing). It has decreased from 170.00 Cr. (Mar 2025) to 164.00 Cr., marking a decrease of 6.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 83.00 Cr.. The value appears strong and on an upward trend. It has increased from 81.00 Cr. (Mar 2025) to 83.00 Cr., marking an increase of 2.00 Cr..
- For CWIP, as of Sep 2025, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Mar 2025) to 2.00 Cr., marking a decrease of 2.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 80.00 Cr.. The value appears to be declining and may need further review. It has decreased from 86.00 Cr. (Mar 2025) to 80.00 Cr., marking a decrease of 6.00 Cr..
- For Total Assets, as of Sep 2025, the value is 164.00 Cr.. The value appears to be declining and may need further review. It has decreased from 170.00 Cr. (Mar 2025) to 164.00 Cr., marking a decrease of 6.00 Cr..
Notably, the Reserves (133.00 Cr.) exceed the Borrowings (2.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 17.00 | 18.00 | 20.00 | 29.00 | 23.00 | 20.00 | 17.00 | 10.00 | 30.00 | 25.00 | 38.00 | 40.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 61 | 50 | 59 | 60 | 57 | 52 | 66 | 76 | 75 | 64 | 58 | 65 |
| Inventory Days | 156 | 142 | 149 | 158 | 179 | 159 | 158 | 143 | 136 | 124 | 116 | 100 |
| Days Payable | 232 | 116 | 119 | 129 | 176 | 161 | 145 | 178 | 154 | 146 | 185 | 164 |
| Cash Conversion Cycle | -15 | 75 | 89 | 89 | 60 | 49 | 78 | 41 | 57 | 42 | -11 | 2 |
| Working Capital Days | 41 | 69 | 67 | 5 | 60 | 44 | 62 | 33 | 71 | 48 | 16 | 39 |
| ROCE % | 27% | 19% | 24% | 36% | 25% | 23% | 18% | 8% | 39% | 18% | 28% | 30% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 17 | Mar 16 | Mar 15 | Mar 14 | Mar 13 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 51.87 | 35.67 | 20.57 | 30.16 | 34.37 |
| Diluted EPS (Rs.) | 51.87 | 35.67 | 20.57 | 30.16 | 34.37 |
| Cash EPS (Rs.) | 75.38 | 66.81 | 52.61 | 51.15 | 55.75 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 343.51 | 285.76 | 253.44 | 234.62 | 204.61 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 343.51 | 285.76 | 253.44 | 234.62 | 204.61 |
| Revenue From Operations / Share (Rs.) | 397.75 | 392.35 | 393.06 | 360.68 | 357.27 |
| PBDIT / Share (Rs.) | 109.55 | 95.26 | 71.70 | 72.15 | 81.96 |
| PBIT / Share (Rs.) | 91.91 | 65.59 | 39.72 | 52.18 | 65.20 |
| PBT / Share (Rs.) | 91.91 | 65.59 | 39.70 | 50.95 | 65.06 |
| Net Profit / Share (Rs.) | 57.74 | 37.14 | 20.62 | 31.18 | 38.99 |
| NP After MI And SOA / Share (Rs.) | 51.87 | 35.67 | 20.57 | 30.16 | 34.37 |
| PBDIT Margin (%) | 27.54 | 24.28 | 18.24 | 20.00 | 22.94 |
| PBIT Margin (%) | 23.10 | 16.71 | 10.10 | 14.46 | 18.25 |
| PBT Margin (%) | 23.10 | 16.71 | 10.09 | 14.12 | 18.20 |
| Net Profit Margin (%) | 14.51 | 9.46 | 5.24 | 8.64 | 10.91 |
| NP After MI And SOA Margin (%) | 13.04 | 9.09 | 5.23 | 8.36 | 9.62 |
| Return on Networth / Equity (%) | 16.56 | 13.64 | 8.92 | 14.24 | 18.81 |
| Return on Capital Employeed (%) | 26.60 | 22.62 | 15.54 | 21.43 | 30.91 |
| Return On Assets (%) | 12.30 | 9.59 | 6.28 | 8.50 | 10.51 |
| Asset Turnover Ratio (%) | 1.00 | 0.98 | 1.02 | 0.92 | 1.00 |
| Current Ratio (X) | 4.01 | 3.14 | 2.71 | 1.92 | 1.67 |
| Quick Ratio (X) | 3.27 | 2.41 | 1.87 | 1.33 | 1.11 |
| Inventory Turnover Ratio (X) | 2.26 | 2.14 | 2.25 | 2.07 | 2.12 |
| Dividend Payout Ratio (NP) (%) | 0.00 | 11.21 | 4.86 | 3.31 | 2.90 |
| Dividend Payout Ratio (CP) (%) | 0.00 | 6.12 | 1.90 | 1.99 | 1.95 |
| Earning Retention Ratio (%) | 0.00 | 88.79 | 95.14 | 96.69 | 97.10 |
| Cash Earning Retention Ratio (%) | 0.00 | 93.88 | 98.10 | 98.01 | 98.05 |
| Interest Coverage Ratio (X) | 0.00 | 0.00 | 2707.05 | 58.75 | 569.16 |
| Interest Coverage Ratio (Post Tax) (X) | 0.00 | 0.00 | 779.53 | 26.39 | 271.76 |
| Enterprise Value (Cr.) | 210.89 | 92.31 | 144.85 | 65.34 | 77.58 |
| EV / Net Operating Revenue (X) | 1.89 | 0.84 | 1.32 | 0.64 | 0.77 |
| EV / EBITDA (X) | 6.87 | 3.46 | 7.21 | 3.23 | 3.38 |
| MarketCap / Net Operating Revenue (X) | 2.23 | 1.04 | 1.39 | 0.75 | 0.85 |
| Retention Ratios (%) | 0.00 | 88.78 | 95.13 | 96.68 | 97.09 |
| Price / BV (X) | 2.83 | 1.56 | 2.38 | 1.29 | 1.68 |
| Price / Net Operating Revenue (X) | 2.23 | 1.04 | 1.39 | 0.75 | 0.85 |
| EarningsYield | 0.05 | 0.08 | 0.03 | 0.11 | 0.11 |
After reviewing the key financial ratios for Morganite Crucible (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 17, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 16) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 17, the value is 51.87. This value is within the healthy range. It has increased from 35.67 (Mar 16) to 51.87, marking an increase of 16.20.
- For Diluted EPS (Rs.), as of Mar 17, the value is 51.87. This value is within the healthy range. It has increased from 35.67 (Mar 16) to 51.87, marking an increase of 16.20.
- For Cash EPS (Rs.), as of Mar 17, the value is 75.38. This value is within the healthy range. It has increased from 66.81 (Mar 16) to 75.38, marking an increase of 8.57.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 17, the value is 343.51. It has increased from 285.76 (Mar 16) to 343.51, marking an increase of 57.75.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 17, the value is 343.51. It has increased from 285.76 (Mar 16) to 343.51, marking an increase of 57.75.
- For Revenue From Operations / Share (Rs.), as of Mar 17, the value is 397.75. It has increased from 392.35 (Mar 16) to 397.75, marking an increase of 5.40.
- For PBDIT / Share (Rs.), as of Mar 17, the value is 109.55. This value is within the healthy range. It has increased from 95.26 (Mar 16) to 109.55, marking an increase of 14.29.
- For PBIT / Share (Rs.), as of Mar 17, the value is 91.91. This value is within the healthy range. It has increased from 65.59 (Mar 16) to 91.91, marking an increase of 26.32.
- For PBT / Share (Rs.), as of Mar 17, the value is 91.91. This value is within the healthy range. It has increased from 65.59 (Mar 16) to 91.91, marking an increase of 26.32.
- For Net Profit / Share (Rs.), as of Mar 17, the value is 57.74. This value is within the healthy range. It has increased from 37.14 (Mar 16) to 57.74, marking an increase of 20.60.
- For NP After MI And SOA / Share (Rs.), as of Mar 17, the value is 51.87. This value is within the healthy range. It has increased from 35.67 (Mar 16) to 51.87, marking an increase of 16.20.
- For PBDIT Margin (%), as of Mar 17, the value is 27.54. This value is within the healthy range. It has increased from 24.28 (Mar 16) to 27.54, marking an increase of 3.26.
- For PBIT Margin (%), as of Mar 17, the value is 23.10. This value exceeds the healthy maximum of 20. It has increased from 16.71 (Mar 16) to 23.10, marking an increase of 6.39.
- For PBT Margin (%), as of Mar 17, the value is 23.10. This value is within the healthy range. It has increased from 16.71 (Mar 16) to 23.10, marking an increase of 6.39.
- For Net Profit Margin (%), as of Mar 17, the value is 14.51. This value exceeds the healthy maximum of 10. It has increased from 9.46 (Mar 16) to 14.51, marking an increase of 5.05.
- For NP After MI And SOA Margin (%), as of Mar 17, the value is 13.04. This value is within the healthy range. It has increased from 9.09 (Mar 16) to 13.04, marking an increase of 3.95.
- For Return on Networth / Equity (%), as of Mar 17, the value is 16.56. This value is within the healthy range. It has increased from 13.64 (Mar 16) to 16.56, marking an increase of 2.92.
- For Return on Capital Employeed (%), as of Mar 17, the value is 26.60. This value is within the healthy range. It has increased from 22.62 (Mar 16) to 26.60, marking an increase of 3.98.
- For Return On Assets (%), as of Mar 17, the value is 12.30. This value is within the healthy range. It has increased from 9.59 (Mar 16) to 12.30, marking an increase of 2.71.
- For Asset Turnover Ratio (%), as of Mar 17, the value is 1.00. It has increased from 0.98 (Mar 16) to 1.00, marking an increase of 0.02.
- For Current Ratio (X), as of Mar 17, the value is 4.01. This value exceeds the healthy maximum of 3. It has increased from 3.14 (Mar 16) to 4.01, marking an increase of 0.87.
- For Quick Ratio (X), as of Mar 17, the value is 3.27. This value exceeds the healthy maximum of 2. It has increased from 2.41 (Mar 16) to 3.27, marking an increase of 0.86.
- For Inventory Turnover Ratio (X), as of Mar 17, the value is 2.26. This value is below the healthy minimum of 4. It has increased from 2.14 (Mar 16) to 2.26, marking an increase of 0.12.
- For Dividend Payout Ratio (NP) (%), as of Mar 17, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 11.21 (Mar 16) to 0.00, marking a decrease of 11.21.
- For Dividend Payout Ratio (CP) (%), as of Mar 17, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 6.12 (Mar 16) to 0.00, marking a decrease of 6.12.
- For Earning Retention Ratio (%), as of Mar 17, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 88.79 (Mar 16) to 0.00, marking a decrease of 88.79.
- For Cash Earning Retention Ratio (%), as of Mar 17, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 93.88 (Mar 16) to 0.00, marking a decrease of 93.88.
- For Interest Coverage Ratio (X), as of Mar 17, the value is 0.00. This value is below the healthy minimum of 3. There is no change compared to the previous period (Mar 16) which recorded 0.00.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 17, the value is 0.00. This value is below the healthy minimum of 3. There is no change compared to the previous period (Mar 16) which recorded 0.00.
- For Enterprise Value (Cr.), as of Mar 17, the value is 210.89. It has increased from 92.31 (Mar 16) to 210.89, marking an increase of 118.58.
- For EV / Net Operating Revenue (X), as of Mar 17, the value is 1.89. This value is within the healthy range. It has increased from 0.84 (Mar 16) to 1.89, marking an increase of 1.05.
- For EV / EBITDA (X), as of Mar 17, the value is 6.87. This value is within the healthy range. It has increased from 3.46 (Mar 16) to 6.87, marking an increase of 3.41.
- For MarketCap / Net Operating Revenue (X), as of Mar 17, the value is 2.23. This value is within the healthy range. It has increased from 1.04 (Mar 16) to 2.23, marking an increase of 1.19.
- For Retention Ratios (%), as of Mar 17, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 88.78 (Mar 16) to 0.00, marking a decrease of 88.78.
- For Price / BV (X), as of Mar 17, the value is 2.83. This value is within the healthy range. It has increased from 1.56 (Mar 16) to 2.83, marking an increase of 1.27.
- For Price / Net Operating Revenue (X), as of Mar 17, the value is 2.23. This value is within the healthy range. It has increased from 1.04 (Mar 16) to 2.23, marking an increase of 1.19.
- For EarningsYield, as of Mar 17, the value is 0.05. This value is below the healthy minimum of 5. It has decreased from 0.08 (Mar 16) to 0.05, marking a decrease of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Morganite Crucible (India) Ltd:
- Net Profit Margin: 14.51%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 26.6% (Industry Average ROCE: 18.1%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 16.56% (Industry Average ROE: 13.55%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.27
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 32.6 (Industry average Stock P/E: 34.55)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 14.51%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Refractories | B-11, MIDC Waluj, Aurangabad Maharashtra 431136 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Ms. Poonam Bopshetti | Director |
| Mr. Aniruddha Karve | Director |
| Mr. Jonathan Percival | Director |
| Ms. Maithilee Tambolkar | Independent Director |
| Mr. Ulhas Gaoli | Independent Director |
| Mr. Chandrashekhar Chitale | Independent Director |
FAQ
What is the intrinsic value of Morganite Crucible (India) Ltd?
Morganite Crucible (India) Ltd's intrinsic value (as of 14 January 2026) is ₹1395.61 which is 5.06% lower the current market price of ₹1,470.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹823 Cr. market cap, FY2025-2026 high/low of ₹1,964/1,170, reserves of ₹133 Cr, and liabilities of ₹164 Cr.
What is the Market Cap of Morganite Crucible (India) Ltd?
The Market Cap of Morganite Crucible (India) Ltd is 823 Cr..
What is the current Stock Price of Morganite Crucible (India) Ltd as on 14 January 2026?
The current stock price of Morganite Crucible (India) Ltd as on 14 January 2026 is ₹1,470.
What is the High / Low of Morganite Crucible (India) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Morganite Crucible (India) Ltd stocks is ₹1,964/1,170.
What is the Stock P/E of Morganite Crucible (India) Ltd?
The Stock P/E of Morganite Crucible (India) Ltd is 32.6.
What is the Book Value of Morganite Crucible (India) Ltd?
The Book Value of Morganite Crucible (India) Ltd is 242.
What is the Dividend Yield of Morganite Crucible (India) Ltd?
The Dividend Yield of Morganite Crucible (India) Ltd is 3.33 %.
What is the ROCE of Morganite Crucible (India) Ltd?
The ROCE of Morganite Crucible (India) Ltd is 30.4 %.
What is the ROE of Morganite Crucible (India) Ltd?
The ROE of Morganite Crucible (India) Ltd is 21.4 %.
What is the Face Value of Morganite Crucible (India) Ltd?
The Face Value of Morganite Crucible (India) Ltd is 5.00.